Recent research has shown promising early results in re-activating a protein associated with rapid wound healing. The protein quickly...

Adult and pediatric AD patients have experienced more adverse effects after prolonged use of corticosteroids.

An early investigational report indicates that a compound derived from baby spinach leaves may be developed into an effective topical...

Findings from a study of patients with stage III melanoma treated with a combination of the immune checkpoint inhibitors relatlimab and...

Tralokinumab treatment in patients with AD does not increase Covid-19 severity or interfere with Covid-19 vaccinations.

Researchers at Emory University in Atlanta have synthesized a novel molecule called indolium 1 that blocks the growth of melanoma cells,...

Findings from a literature review examining the impact of extreme weather events on skin health suggest that climate change will worsen...

A digitally delivered intervention showed significant improvements in treatment adherence and other clinical outcomes in AD patients.